About
Juvenescence Ltd. is a biotechnology company dedicated to the research and development of novel therapies aimed at combating aging and age-related diseases. The company's focus is on identifying and advancing interventions that can extend human healthspan and lifespan, thereby improving the quality of life for older adults.
Key facts
At-a-glance profile data
- Website
- juvenescence.com
- Headquarters
- George Town, Cayman Islands
- Founded
- 2017
- Total funding
- $150M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jul 2018 | Series B | $100M | Jefferies Financial Group Inc. |
| 1 Jan 2017 | Seed | $50M | - |
“Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42.”
View on Reddit“G3 and Juvenescence partner on deep learning venture - Longevity.Technology.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has Juvenescence Ltd. raised?
Juvenescence Ltd. has raised a total of $150M in funding. The most recent round on record is Series B.